menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Understanding the Role of the Alternate Complement Pathway in PNH

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
  • Sponsored by

  • Overview

    Paroxysmal nocturnal hemoglobinuria (PNH) is a relatively rare and acquired disorder in which the stem cells become abnormally mutated and no longer produce the PIG-A 
    protein.1.2 So then what happens to patients with PNH? Join Dr Jennifer Caudle as she discusses this with Dr Catherine Broome, Associate Professor in the Department of Medicine at the Georgetown Lombardi Comprehensive Cancer Center.

    References:

    1.  Notaro R et al. N Engl J Med. 2022;387(2):160-166. doi:10.1056/NEJMra2201664 2.
    2. Risitano AM, et al. Immunol Rev. 2023;313(1):262-278. doi:10.1111/imr.13137

     

    283987     9/23

Recommended
Details
Presenters
Related
  • Sponsored by

  • Overview

    Paroxysmal nocturnal hemoglobinuria (PNH) is a relatively rare and acquired disorder in which the stem cells become abnormally mutated and no longer produce the PIG-A 
    protein.1.2 So then what happens to patients with PNH? Join Dr Jennifer Caudle as she discusses this with Dr Catherine Broome, Associate Professor in the Department of Medicine at the Georgetown Lombardi Comprehensive Cancer Center.

    References:

    1.  Notaro R et al. N Engl J Med. 2022;387(2):160-166. doi:10.1056/NEJMra2201664 2.
    2. Risitano AM, et al. Immunol Rev. 2023;313(1):262-278. doi:10.1111/imr.13137

     

    283987     9/23

Schedule30 May 2024